Overview
Inhibits matrix metalloproteinases (MMPs), binds to and protects damaged cartilage proteoglycans.
Proposed mechanism
PPS is a semi-synthetic glycosaminoglycan that reduces cartilage degradation, inhibits inflammatory cytokines (IL-6, TNF-α), and restores bladder glycosaminoglycan layer.
What the evidence supports
Human data exists but the trials are small, short-term, or not yet replicated.
Graded Human-limited
Human data that exists but is thin: open-label work, single-arm studies, small cohorts, or observational follow-up without randomisation.
Key citations
Representative primary sources, including results that did not favour the compound.
- [1]
PPS for OA
· DOI:10.1002/art.1780360409 · 1993
- [2]
PPS in cystitis
· DOI:10.1097/01.ju.0000136199.71257.27 · 2004
- [3]
PPS for OA (1993)
· · 0
- [4]
PPS in cystitis (2004)
· · 0
Citation records in this build are illustrative placeholders for the design.
Reference information for research purposes. Not medical advice, and not a recommendation to use any compound. Many entries describe substances that are not approved for human use.